Results
Omkar Speciality Chemicals Approves Delayed FY25 Quarterly Results
Omkar Speciality Chemicals' Monitoring Committee approved unaudited financial results for Q1, Q2, and Q3 of FY25, all reporting zero revenue and significant losses.
The company, emerging from CIRP, ap
